BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kojc N, Bahovec A, Levart TK. C3 glomerulopathy in children: Is there still a place for anti-cellular immunosuppression? Nephrology (Carlton) 2019;24:188-94. [PMID: 30393898 DOI: 10.1111/nep.13522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Pınarbaşı AS, Dursun I, Gokce I, Çomak E, Saygılı S, Bayram MT, Donmez O, Melek E, Tekcan D, Çiçek N, Yılmaz D, Tabel Y, Yıldırım ZY, Bahat E, Koyun M, Soylu A, Canpolat N, Aksu B, Çelakıl ME, Taşdemir M, Benzer M, Özçelik G, Bakkaloğlu SA, Düşünsel R. Predictors of poor kidney outcome in children with C3 glomerulopathy. Pediatr Nephrol 2021;36:1195-205. [PMID: 33130981 DOI: 10.1007/s00467-020-04799-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zahir Z, Wani AS, Gupta A, Agrawal V. Pediatric C3 glomerulopathy: a 12-year single-center experience. Pediatr Nephrol 2021;36:601-10. [PMID: 33000324 DOI: 10.1007/s00467-020-04768-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Prakash R, Ali US, Ohri A, Parekhji SN, Deokar A, Khubchandani S. Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children. Indian J Nephrol 2020;30:370-6. [PMID: 33840955 DOI: 10.4103/ijn.IJN_226_18] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]